Visit Claire Rothery 's profile on the York Research Database to:
- See a full list of publications
- Browse activities and projects
- Explore connections, collaborators, related work and more
Claire Rothery is a Professor of Health Economics in the Team for Economic Evaluation and Health Technology Assessment (TEEHTA). She joined the Centre for Health Economics (CHE) in 2006 after completing the MSc in Health Economics at York. She holds a MSci in Mathematics (2001), PhD in Theoretical Physics (2004), and MPhil in Medical Statistics (2005), all awarded by Queen's University Belfast, Northern Ireland.
Claire leads the Technology Assessment Reviews (TAR) programme of work within CHE for the UK National Institute for Health and Care Excellence (NICE), which supports the role of NICE in improving outcomes for people using the NHS and other public health and social care services by ensuring that national guidance for new pharmaceuticals, interventional procedures, devices and diagnostic technologies are underpinned by rigorous and independent assessments of clinical effectiveness and value for money.
Claire has over 15 years’ experience working on the NICE programme, progressing from a research analyst on projects, through to project lead, and now leadership of the programme. She also served on the NICE Technology Appraisal Committee from 2013-2016 and has been a member of the NICE Decision Support Unit since 2012. Claire has been closely involved in developing and refining the methods used in technology assessment and has contributed to the most recent NICE methods and processes review, with updated NICE manual published in 2022.
Her principal areas of expertise relate to the methodology and application of decision-analytic modelling and Bayesian approaches to Health Technology Assessment. She has specific interests in the use of constrained optimisation methods in economic evaluation and methodological and applied research on improving efficiency in the prioritisation and commissioning of research in health care, including the characterisation of uncertainty in health care decisions and value of information methods to inform research prioritisation decisions. Claire co-chaired the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Emerging Good Practices for Value of Information analysis and is a member of the international consortium for Value of Information (ConVOI).
Claire has received a number of distinguished international awards for her research, including the 2011 Society for Medical Decision Making (SMDM) award for Outstanding Paper by a Young Investigator, ISPOR’s 2017 Excellence in Methodology in Pharmacoeconomics and Health Outcomes Research Award and in 2018 ISPOR Award for a Distinguished Researcher.